LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Ghosh, Monimoy
Languages: English
Types: Doctoral thesis
Subjects: RC0254
In spite of extensive research there is little information about apoptosis or programmed cell death in the genesis and progression of cancers of the lung. In our project we have investigated the role of apoptosis and two of the genes controlling apoptosis (bcl2 and C040) in squamous cell carcinoma of the lung. Also we have tried to formulate an accurate way of measuring apoptotic rate in tumour specimens.\ud \ud We counted apoptotic cells in Haematoxylin and Eosin stained histological sections of squamous cell carcinoma of the lung. The apoptotic indices we obtained were very reliable showing remarkable reproducibility and strong correlation with apoptosis measured by monoclonal antibody to apoptosis specific protein (ASP). In our series apoptotic index did not correlate with survival, disease stage, differentiation, AgNOR or DNA ploidy.\ud \ud Histological sections were stained with monoclonal antibodies to Bc12 and CD40. In all, 32% of squamous cell carcinoma of lung were Bc12 positive (i.e. more than 50% of the tumour cells contained Bc12 protein) and 22% were positive for C040. The expression of Bc12 correlated positively with the apoptotic indices. Patients with Bcl2 positive squamous cell lung cancers survived significantly longer although Bcl2 expression did not correlate with any marker of disease severity e.g. stage, grade, AgNOR or DNA ploidy.\ud \ud C040 expression in squamous cell lung cancer had no effect on apoptosis, survival or any of the other previously mentioned markers of disease severity. The expression of C040 in our series showed a tendency to correlate inversely with the expression of Bcl2. \ud \ud We devised a way to measure apoptotie rate in prinwy cultures of tumour cells by serial estimation of sub-diploid fractions in cell suspensions double stained with PI and BerEP4-FITC. We believe that the apoptotic rate measured in this fashion is biologically more relevant, and therefore could be more useful in predicting prognosis, than apoptosis measured from histological sections.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • McDonneU, T. J., Troncoso, P., Brisbay, S. M., Logothetis, C., Chung, L. W. K., Hsieh, J. T., Tu, S. M., CampbeU, M. L. (1992). Expression of the protooncogene bc12 in the prostate and its association with emergence of androgen independent prostate cancer. Cancer Res. 52,6940-6944.
    • Meredith, J. E., Fazeli, B., Schwartz, M. A. (1993). The extracellular matrix as a cell survival factor. Mol. Bioi. Cell. 4, 953-961.
    • Minn, A. Jo, Velez, Po, Schendel, So Lo, Liang, Ho, Muchmore, S. Wo, Fesik, So Wo, Fill, Mo, Thompson, Co Bo (1997). Bel-xL forms an ion channel in synthetic lipid membranes. Nature. 385, 353-357.
    • Minna, Jo Do (1991). Neoplasms of the lung. In Harrison's Principles of Internal Medicine, 11th Edition, pp 1115 - 1123. Edited by Braunwald, E., Isselbacher, K. J., Petersdorf, R G., Wdson, J. D., Martin, 1. B., Fauci, A. S. McGraw Hill Inc.
    • Moralesducret, Co R. Jo, van Derijn, M., Lebrun, D. Po, SmoUer, B. R. (1995). Bel2 expression in primary malignancies of the skin. Archives ofDermatology. 131,909-912.
    • Moriera, L Fo, Naomoto, Yo, Hamada, Mo, Kamikawa, Yo, Orita, K. (1995). Assessment of apoptosis in oesophageal carcinoma preoperatively treated by chemotherapy and radiotherapy. Anticancer Res. 15,639-644.
    • Motoyama, No, Wang, Fo, Roth, K. A., Sawa, H., Nakayama, K., Negisbi, L, Senju, S., Zhang, Qo, Fujii, So, Loh, Do Y. (1995). Massive cell death of immature haemopoietic cells and neurons in Bcl-x deficient mice. Science. 267, 1506-1510.
    • Mountain, Co Fo (1985). The biologic operability of stage III non-small cell lung cancer. Ann. Thorac. Surg. 40,60-64.
    • Mountain, C. F. (1995). New prognostic factors in lung cancer: biologic prophets of cancer cell aggression. Chest. 108,246-255.
    • Mueller, J., MueHer, E., Hoepner, I., Jutting, J., Bethke, B., Stolte, M., Hofler, H. (1996). Expression of Bc12 and p53 in de-novo and ex-adenoma colon carcinoma - a comparative immunohistochemical study. J. Pathol. 180,259-265.
    • Mundie, S. D., Gao, X. Z., Kban, S., Gregory, S. A., Preisler, H. D., Raza, A. (1995). Two in situ labelling techniques reveal different patterns of DNA fragmentation during spontaneous apoptosis in vivo and induced apoptosis in vitro. Anticancer Res. 15, 1895- 1904.
    • Nagy, L., Tbomazy, V. A., Cbandraratna, R. A. S., Heyman, R. A., Davies, P. J. A. (1996): Retinoid regulated expression of bcl2 and tissue transglutarninase during the differentiation and apoptosis of human myeloid leukaemia (HL-60) cells. Leukaemia Research. 20, 499-505.
    • Nakagawa, T., Mabry, Mo, de Bustros, A., Ible, J. N., Nelkin, Bo D., Baylin, S. B. (1987). Introduction of the v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells. Proc. Natl. Acad Sci. USA. 84, 5923-5927.
    • Nakamura, To, Nomura, So, Sakai, To, Nariya, S. (1997). Expression of bcl2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions. Human Pathology. 28, 309-315.
    • Nakayama, K., Nakayama, K., Dustin, Lo Bo, Lob, D. Y. (1995). T-B cell interaction inhibits spontaneous apoptosis of mature lymphocytes in Bcl2 deficient mice. J. Exp. Med. 182, 1101-1107.
    • Nataraj, A., Pathak, S., Hopwood, V. L., McDonnell, T. J., Ananthaswamy, H. N. (1994). Bcl2 oncogene blocks differentiation and extends viability but does not immortalize normal human keratinocytes.lnt. J. Oncol.4, 1211-1218.
    • Nathan, B., Gustenon, B., Jadayel, D., Ohare, M., Anbazhagan, R., Jayatilake, H., Ebbs, S., Micidem, K., Price, K., Gelber, R., Reed, R., SenD, H. J., Goldhinch, A., Dyer, M. J. S. (1994). Expression of Bc12 in primary breast cancer and its correlation with tumour phenotype. Annal. Oneol. 5, 409-414.
    • Nawrocki, B., Polette, M., Marchand, V., Monteau, M., Gillery, P., Toumier, J. M., Birembaut, P. (1997). Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinoma: quantificative and morphological analysis. Int. J. Cancer. 72, 556-564.
    • Nettesheim, P., Creasia, D. A., Mitchell, T. J. (1975). Carcinogenic and cocarcinogenic effects of inhaled synthetic smog and ferric oxide particles. J. Natl. Cancer Insl. 55, 159-162.
    • Nicholson, D. W. (1996): ICFiCED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nature Biotechnology. 14,297-301.
    • Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bunch, W., Schulte--Hermann, R. (1992). Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor pI. Proc. Natl. Acad.
    • Sci. USA. 89, 5408-5412.
    • Office of Population Censuses and Surveys (1987): Mortality statistics, cause; Series DH2 no. 12. HMSO, London.
    • orner, Do, Riehemann, Ko, Maier, Ho, Riedmann, Bo, Nehoda, Ho, Totsch, M., Boeker, W., Jasani, B., Schmid, K. W. (1995). Immunohistochemically detectable Bel2 expression in colorectal carcinoma - correlation with tumour stage and patient survival. Br. J. Cancer. 72, 981-985.
    • Ogasawara, J., Watanabe-Fukunaga, a, Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., Nagata, S. (1993). Lethal effects of anti-Fas antibody in mice. Nature. 364, 806-809.
    • Ogrady, J. T. Stewart, S., Lowrey, J., Howie, S. E. M., Krajewski, A. S. (1994). CD40 expression in Hodgkins disease. Am. J. Pathol. 144,21-26.
    • Ohashi, K., Nemoto, T., Eishi, Y., Matsuno, A., Nakamura, K., Hirokawa, K. (1997). Proliferative activity and p53 protein accumulation correlate with early invasive trend and apoptosis correlates with differentiation grade in oesophageal squamous cell carcinomas. Virchows Archiv - An internationaljournal ofpathology. 430, 107-115.
    • Ohbu, M., Saegusa, M., Kobayashi, N., Tsukamoto, H., Mieno, H., Kakita, A., Okayasu, L (1997). Expression of Bcl2 protein in oesophageal squamous cell carcinomas and its association with lymph node metastasis. Cancer. 79, 1287-1293.
    • Ohbu, M., Saegusa, M., Okayasu, I. (1995). Apoptosis and cellular proliferation in oesophageal squamous cell carcinomas - differences between keratinizing and nonkeratinizing types. Virchows Archiv - An international journal of pathology. 427, 271- 276.
    • Ohmori, T., Podack, E. a, Nishio, K., Takahashi, M., Miyahara, Y., Takeda, Y., Kubota, N., Funayama, Y., Ogasawara, H., Obira, T., Obta, S., Saijo, N. (1993). Apoptosis of lung cancer cells caused by some anti cancer agents (MMe, CPT-II, ADM) is inhibited by bc12. Biochemical and Biophysical Research Communications. 192, 30-36.
    • Ohsaki, Y., Toyoshima, E., Fujiuchi, S., Matsui, H., Hirata, S., Miyokawa, N., Kubo, A., Kikuchi, K. (1996). Bel2 and p53 protein expression in NSCLCs: correlation with survival time. Clin. Cancer Res. 2,915-920.
    • Olopade, O. L, Adeyanju, M. 0., Safa, A. R., Bagos, F., Mick, R., Thompson, C. B., Recant, W. M. (1997). Overexpression of Bcl-x protein in primary breast cancer is associated with high tumour grade and nodal metastases. Cancer Journal from SCientific American 3,230-237.
    • Oltvai, Z. N., MiUiman, C. L., Korsmeyer, S. J. (1993). Bel2 heterodimerizes in vivo with a conserved homolg, Bax, that accelerates programmed cell death. Cell. 74,609-614.
    • OneiU, A. J., Staunton, M. J., Gaffney, E. F. (1996). Apoptosis occurs independently of bcl2 and p53 in NSCLC. Histopathology. 29,45-50.
    • OreiUy, M. S., Holmgren, L., Chen, C., Folkman, J. (1996). Angiostatin induces and sustains dormancy of human primary tumours in mice. Nature Medicine. 2, 689-692.
    • Packham, G. and Cleveland, J. L. (1995): c-Myc and apoptosis. Biochimica et Biophysica Acta. 1242, 11-28.
    • Panchalingam, S., Reynolds, G. M., Lammas, D. A., Rowlands, D., Kumararatne, D. S. (1996). Simple method for pretreatment of tissue sections for the detection of apoptosis by in situ end labelling and in situ nick translation. 1. Clin. Pathol.: Mol. Pathol. 49, M273-277.
    • Parangi, S., OreiDy, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., Hanahan, D. (1996). Antiangiogenic therapy of transgenic mice impairs de-novo tumour growth. Proc. Natl. Acad. Sci. USA. 93, 2002-2007.
    • Pastorino, U., Andreola, S., Tagliabue, E., Pezzella, F., Incarbone, M., Sozzi, G., Buyse, M., Menard, S., Pierotti, M., Rilke, F. (1997). Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J. Clin. Oncol. 15,2858-2865.
    • Patel, D. D., Bhatavdekar, J. M., Chiklikar, P. a, Patel, Y. V., Shah, N. G., Ghosh, N., Suthar, T. P., Balar, D. B. (1997). Clinical signioficance of p53, nm23, and bcl2 in T3-4NIMO oesophageal carcinoma: an immunohistochemical approach. J. Surg. Oncol. 65, 111-116.
    • Patton, M. M., McDonald, J. a, Moersch, H. J. (1951). Bronchogenic large cell carcinoma J. Ihorac. Surg. 22, 88-93.
    • Pearson, G. a, Lub, J., Petti, L., Sample, J., Birkenback, M., Braun, D., KiefT, E. (1987). Identification ofan Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology. 160, 151-155.
    • Pereira, H., Silva, S., Juliao, a, Garcia, P., Perpetua, F. (1997). Prognostic markers for colorectal cancer: expression ofp53 and bcl2. World Journal ofSurgery. 21, 210-213.
    • Pezzella, M. D., Turley, H., Kuzu, L, Tungekar, M. H., DunniUi, M. S., Pierce, C. B., Barris, A., Gatter, K. C., Mason, D. Y. (1993). Bcl2 protein in NSCLC. New Engl. J. Med. 329,690-694.
    • Pietenpol, J. A., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W., Vogelstein, B. (1994). Paradoxical inhibition of solid tumour cell growth by bc12. Cancer Res. 54,3714-3717.
    • 1(., Berman, B. (1996): The presence of human papillomavirus-16/-18 E6, p53, and Bcl2 Reed, J. C., Tsujimoto, Y., Alpers, J. D., Croce, C. M., Nowell, P. C. (1987). Regulation of bcl2 protooncogene expression during normal human lymphocyte proliferation. Science. 236, 1295-1299.
    • Reeve, J. G., Xiong, J., Morgan, J., Bleehan, N. M. (1996). Expression of apoptosis regulatory genes in lung tumour cell lines - relationship to p53 expression and relevance to acquired drug resistance. Br. J. Cancer. 73, 1193-1200.
    • Richardson, G. E. and Johnson, B. E. (1993): The biology of lung cancer. Sem. Oncol. 20, 105-127.
    • Ritter, J. H., Dresler, C. M., Wick, M. R. (1995). Expression of bcl2 protein in stage TINOMO NSCLC. Human Pathology. 26, 1227-1232.
    • Rokhlin, O. W., Bishop, G. A., Hostager, B. S., Waldschmidt, T. J., Sidorenko, S. P., PavlotT, N., Kiefer, M. C., Umansky, S. R., Glover, R. A., Cohen, M. B. (1997): Fas mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res. 57, 1758-1768.
    • Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., Pisters, K. M. W., Putnam, J. B., Schea, R., Shin, D. M., Walsh, G. L., Dolormente, M. M., Han, C-I., Martin, F. D., Yen, N., Xu, K., Stephens, L. C., McDonnell, T. J., Mukhopadhyay, T., Cai, D. (1996). Retrovirus mediated wild type p53 gene transfer to tumours of patients with lung cancer. Nature Medicine. 2, 985-991.
    • Ryan, K. M. and Birnie, G. D. (1996): Myc oncogenes: the enigmatic family. Biochem. J. 314, 713-72l.
    • Saegusa, M., Takaoo, Y., Hashimura, M., Shoji, Y., Okayasu, I. (1995a). The possible role of Bcl2 expression in the progression of tumours of the uterine cervix. Cancer. 76,2297-2303.
    • Sarma, V., Lin, Z., Clark, L., Rust, B. M., Tewari, M., Noelle, R., Dixit, V. M. (1995). Activation of the B cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Bioi. Chem. 270, 12343-12346.
    • Schattner, E. J., Elkon, K. B., Yoo, D. H., Tumang, J., Krammer, • PH., Crow, M. K., Friedman, S. M. (1995). CD40 ligation induces Apo-llFas expression on human B lymphocytes and facilitates apoptosis through the Apo-llFas pathway. J. Exp. Med. 182, 1557-1565.
    • Schneider, H. J., Sampson, S. A., Cunningham, D., Norman, A. R., Andreyev, H. J. N., Tilsed, J. V. T., Clarke, P. A. (1997). Bcl2 expression and response to chemotherapy in colorectal adenocarcinomas. Br. J. Cancer. 7S, 427-431.
    • Seaton, Ao, Seaton, Do, Leitch, Ao G. (1989): Cancer of the lung. In Crofton and Douglas's Respiratory Diseases, 4th Edition, pp 912 - 974. Edited by Seaton, A., Seaton, D., Leitch. A. G. Oxford: Oxford University Press.
    • SelikotT, L J., Hammond, Eo C., Churg, J. (1968). Asbestos exposure, smoking and neoplasia. J. Am. Med Assoc. 204, 104-108.
    • Shao, Zo Mo, Jiang, M., Wu, J., Yu, L. M., Ban, Q. X., Zhang, T. Q., Shen, Z. Z. (19968): Inhibition of apoptosis in human breast cancer as related to prognosis. Oncology Reports. 3, 1183-1186.
    • Shao, Z. M., Jiang, Mo, Wu, Jo, Yu, L. M., Ban, Q. X., Zhang, T. Q., Shen, Zo Z., Fontana, J. A. (1996b). Identification of spontaneous programmed cell death during development of human breast cancer. Oncology Reports. 3, 1133-1136.
    • Sheets, E. E., Cnam, C. P., Yeh, J. (1996). Association between cervical neoplasia and apoptosis as detected by in-situ nuclear labelling. Gynaecologic Oncology. 63,94-100.
    • Sheibani, K., Shin, S. S., Kezirian, J., Weiss, L discriminant in the differential diagnosis of adenocarcinoma. Am. J Surg. Pathol. 15(8), 779-784.
    • Shigihara, Y. and Uoyd, R. V. (1997). Apoptosis and cellular proliferation in skin neoplasms. Applied Immunohistochemistry. 5, 29-34.
    • Shinohara, To, Ohshima, Ko, Murayama, Ho, Kikuchi, Mo, Yamashita, Yo, Shirakusa, To (1996). Apoptosis and proliferation in gastric carcinoma - the association with histological type. Histopathology. 29, 123-129.
    • Sboji, Y., Saegusa, Mo, Takano, Yo, Obbu, M., Okayasu, 1o (1996). Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma. J. Clin. Pathol. 49, 134-138.
    • Skillrud, D. M., OtTord, K. P., Miller, R. D. (1986). Higher risk of lung cancer in chronic obstructive pulmonary disease. Ann. Intern. Med lOS, 503-507.
    • Siebos, R. J. c., Druban, R. H., Dalesio, 0., Mooi, W. J., OtTerhaus, G. J. A., Rodenhuis, S. (l991). Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J. Natl. Cane. Inst. 83, 1024-1027.
    • Terharmsel, B., Smedts, F., Kuijpen, J., Jeunink, Mo, Trimbos, B., Ramaeken, J4~. (1996). Bc12 immunoreactivity increases withnseverity of CIN - a study of normal cervical epithelia, CIN, and cervical carcinoma. J. Pathol. 179,26-30.
    • Testa, J. R. and Siegfried, J. M. (1992). Chromosome abnonnalities in human non small cell lung cancer. Cancer Research. 52, 2702S-2706S.
    • Tsujitani, S., Shirai, H., Tatebe, S., Sugamura, K., Ohfuji, S., Gomyo, Y., Maeta, M., Ito, B., Kaibara, N. (1996). Apoptotic ceO death and its relationship to carcinogenesis in colorectal carcinoma. Cancer. 77, 1711-1716.
    • Tu, H. C., Jacobs, S. c., Borkowski, A., Kyprianou, N. (1996). Incidenece of apoptosis and cell proliferation in prostate cancer-relationship with TGF beta (1) and bel2 expression. Int. J. Cancer. 69, 357-363.
    • Turner-Warwick, M., Lebowitz, M., Johnson, A. (1980). Cryptogenic fibrosing alveolitis and lung cancer. Thorax. 35,496-499.
    • Tuscano, J. M., Druey, K. M., Riva, A., Pena, J., Thompson, C. B., Kehrl, J. H. (1996). Bel-X rather than bcl2 mediates CD40 dependent centrocyte survival in the germinal centre. Blood. 88, 1359-1364.
    • Ueda, N. and Shah, S. V. (1994). Apoptosis. J. Lab. Clin. Med 124, 169-177.
    • van de Schepop, H. A. M., de JODg, J. S., van Diest, P. J., Baak J. P. A. (1996). Counting of apoptotic cells: a methodological study in invasive breast cancer. J. Clin. Pathol.: Mol. Pathol. 49, M214-217 van DeDoord, J. J., Maes, A., Stas, M., Nuyts, J., Battocchio, S., Kasran, A., GannYD, M., Dewever, L, Dewoifpeeten, C. (1996). CD40 is a prognostic marker in primary cutaneous malignant melanoma. Am. J. Pathoi. 149, 1953-1961.
    • Viae, Jo, Schmitt, Do, Claudy, A. (1997). CD40 expression in epidermal tumours. Anticancer Research. 17, 569-572.
    • Watson, A. J. M., Merritt, A. J., Jones, L. S., Askew, J. N., Anderson, E., Becciolini, A., Balzi, M., Potten, C. S., Hickman, J. A. (1996): Evidence for reciprocity of Bcl2 and p53 expression in human colorectal adenomas and carcinomas. Br. J. Cancer. 73, 889-895.
    • Zheng, L. M., Zychlinsky, A., Liu, C-C., Ijcius, D. M., Young, J. D. E. (1991). Extracellular ATP as a trigger for apoptosis or programmed cell death. J. Cell. BioI. 112, 279-288.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article